Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

iOmx Therapeutics Appoints Rüdiger Wolff as Chief Financial Officer

PRIVATEOct 01, 2026
New to company · from CureVac“He most recently served as Senior Vice President Finance at CureVac”

Position

Chief Financial Officer

Company

iOmx Therapeutics AG

Rüdiger Wolff
BavariaBiotechnologyTherapeutics

Description

iOmx Therapeutics AG has announced the appointment of Rüdiger Wolff as Chief Financial Officer, effective immediately. Rüdiger joins iOmx with extensive experience in finance leadership roles within the life sciences and technology sectors.

Company Information

Company

iOmx Therapeutics AG

Location

Bavaria, Germany

About

iOmx Therapeutics is a biotechnology company developing next-generation immuno-oncology therapeutics designed to overcome resistance in solid tumors. iOmx combines tumor immunology expertise with strong biologics development capabilities to advance a pipeline of multimodal therapeutics, including multi-functional antibodies and T cell engagers.

Fundz sees it the moment iOmx Therapeutics AG changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for iOmx Therapeutics AG's next move

Learn about Strategic plan

iOmx Therapeutics AG changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.